• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Vivani Medical, Inc. - Common Stock (NQ: VANI )

    1.250 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 25, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 8
    Open 1.250
    Bid (Size) 1.240 (2)
    Ask (Size) 1.260 (10)
    Prev. Close 1.250
    Today's Range 1.250 - 1.250
    52wk Range 0.8400 - 7.800
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115
    From Vivani Medical, Inc.
    Via Business Wire
    EXCLUSIVE: Vivani Medical Outlines Plans To Kickstart First Clinical Study For Miniature GLP-1 Obesity Implant Program This Year
    Vivani Medical plans to start the first clinical study of the NPM-115 program in Australia in Q4 2024. The study will evaluate a 6-month GLP-1 implant for chronic weight management in obese or... 
    Via Benzinga

    Performance

    YTD
    +20.19%
    +20.19%
    1 Month
    -2.34%
    -2.34%
    3 Month
    -26.25%
    -26.25%
    6 Month
    +21.36%
    +21.36%
    1 Year
    -3.10%
    -3.10%

    More News

    Read More
    Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Why GLP-1 Developer Vivani Medical's Stock Is Climbing
    Via Benzinga
    Exposures Product Safety
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant
    From Vivani Medical, Inc.
    Via Business Wire
    EXCLUSIVE: Vivani Medical's Type 2 Diabetes Treatment NPM-119 Subdermal Implant's NDA Gains FDA Clearance For Clinical Use
    Via Benzinga
    Exposures Product Safety
    Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant
    From Vivani Medical, Inc.
    Via Business Wire
    EXCLUSIVE: Vivani Medical Highlights Weight Loss Data For GLP-1 Implant Supporting Potential Veterinary Use
    Via Benzinga
    VANI Stock Earnings: Vivani Medical Meets EPS for Q1 2024
    Via InvestorPlace
    Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results
    From Vivani Medical, Inc.
    Via Business Wire
    Vivani Medical to Present at TIDES Conference 2024
    From Vivani Medical, Inc.
    Via Business Wire
    VANI Stock Earnings: Vivani Medical Beats EPS for Q4 2023
    Via InvestorPlace
    Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
    From Vivani Medical, Inc.
    Via Business Wire
    Vivani Medical Appoints Daniel Bradbury to its Board of Directors
    From Vivani Medical, Inc.
    Via Business Wire
    Vivani Medical Surges on its Ozempic-Like Weight-Loss Implant
    Via MarketBeat
    Exposures Product Safety
    Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants
    From Vivani Medical, Inc.
    Via Business Wire
    S&P 500 Edges Lower; ADT Posts Upbeat Earnings
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Why Is Vivani Medical (VANI) Stock Up 300% Today?
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.